-+ 0.00%
-+ 0.00%
-+ 0.00%

AKTIS ONCOLOGY - ENROLLMENT ONGOING IN PHASE 1B NECTINIUM-2 TRIAL OF AKY-1189; DATA EXPECTED Q1 2027

Reuters·10/01/2026 12:00:00

Please log in to view news